|
The National Pharmaceutical Council offers a wide variety of printed
and electronic resources. Many are available in hard copy, on CD-ROM,
and as downloadable PDF files.
Hard copies and CD-ROMs are free of charge in small quantities, unless
otherwise noted on the request form.
For bulk or rush orders, you may be asked to pay some printing and/or
shipping costs. You will be contacted if a charge applies to your order.
Free-access PDFs have been provided whenever possible, however some journals
charge a fee for non-subscribers to access articles on their Web sites.
If you are not a journal subscriber, you may choose to purchase the article
directly through the journal's Web site. NPC does not act as an intermediary
for such transactions.
New from NPC!
EBM Landscape Analysis
(Available July 2008)
This reference guide identifies and documents all relevant organizations, activities, proposals, and key individuals associated with the evidence movement in the U.S., including anything of note under the rubric of evidence-based medicine (EBM), comparative effectivess, health (or medical) technology assessment (HTA), etc.
Full report (Updated April 2008)
Executive Summary: Improving and Measuring Osteoporosis Management
(June 2008)
An executive summary of a recent monograph containing 10 voluntary measures of care for osteoporosis. Although osteoporosis is responsible for the majority of hip fractures, and accounts for more than eighteen billion dollars in health care expenditures annually, on average only 20% of patients are ever screened or treated for the disease. The monograph and executive summary were developed by The Joint Commission through an unrestricted educational grant by NPC.
NPC and its new focus on EBM is featured in
a podcast interview with NPC President Dan Leonard
by the on-line journal Genetic Engineering & Biotechnology News (May 2008).
The podcast can be heard via the following link: http://www.genengnews.com/genCasts.aspx
NICE: How does it work and what are the implications for the U.S.?
Executive Summary (April 2008)
Full report (April 2008)
This 4-part project examines the National Institute for Health and Clinical Excellence (NICE) and its operations, and the implications for comparative effectiveness reviews in the U.S.
- Part 1 entails a non-technical overview of NICE, encompassing its governance and organization, topic selection procedures, evidence requirements and assessment methods, and guidance dissemination and implementation.
- Part 2 provides an in-depth investigation of evidence requirements and assessment methods.
- Part 3 involves an analysis of public comments on NICE submitted to the House of Commons Health Select Committee, focusing on key stakeholder perspectives on the appraisal process and broader NICE operations.
- Part 4 examines NICE procedures and standards in the context of the U.S. landscape, and identifies those factors or forces unique to the U.S. marketplace, in comparison to the U.K. and other EU Member States, where applicable.
|
